AstraZeneca, Oxford to produce vaccine effective against COVID-19 variants by Autumn

Published: Updated:

AstraZeneca and Oxford University aim to produce the next generation of COVID-19 vaccines that will protect against variants as soon as the autumn, a senior executive at the British drugmaker said on Wednesday.

For more coronavirus news, visit our dedicated page.

Asked when AstraZeneca could produce a next generation vaccine to tackle new variants, AstraZeneca research chief Mene Pangalos said “as rapidly as possible”.

“We’re working very hard and we’re already talking about not just the variants that we have to make in laboratories, but also the clinical studies that we need to run,” he said in a briefing with media.

“We’re very much aiming to try and have something ready by the autumn, so this year.”

The partners are getting close to having data on the efficacy of their COVID-19 vaccine on older adults, Professor Andrew Pollard, director of the Oxford Vaccine Group, said.

Read more:

Britain says confident that Oxford-AstraZeneca COVID-19 vaccine works for all ages

WHO, GAVI say COVAX distribution plan set to be published

AstraZeneca vaccine explainer: All you need to know after UAE approval